Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options.

Loo V, Salgia M, Bergerot P, Philip EJ, Pal SK.

Target Oncol. 2019 Oct 8. doi: 10.1007/s11523-019-00676-y. [Epub ahead of print] Review.

PMID:
31595385
2.

Predictors of Clostridioidesdifficile Infection among Asymptomatic Colonized Patients: A Retrospective Cohort Study.

Poirier D, Gervais P, Fuchs M, Roussy JF, Paquet-Bolduc B, Trottier S, Longtin J, Loo VG, Longtin Y.

Clin Infect Dis. 2019 Jul 9. pii: ciz626. doi: 10.1093/cid/ciz626. [Epub ahead of print]

PMID:
31290544
3.

Imaging light scattered by a subwavelength nanofiber, from near field to far field.

Loo V, Blanquer G, Joos M, Glorieux Q, De Wilde Y, Krachmalnicoff V.

Opt Express. 2019 Jan 21;27(2):350-357. doi: 10.1364/OE.27.000350.

PMID:
30696122
4.

Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing.

Kong LY, Eyre DW, Corbeil J, Raymond F, Walker AS, Wilcox MH, Crook DW, Michaud S, Toye B, Frost E, Dendukuri N, Schiller I, Bourgault AM, Dascal A, Oughton M, Longtin Y, Poirier L, Brassard P, Turgeon N, Gilca R, Loo VG.

Clin Infect Dis. 2019 Jan 7;68(2):204-209. doi: 10.1093/cid/ciy457.

5.

Detection and Isolation of Clostridium difficile Asymptomatic Carriers During Clostridium difficile Infection Outbreaks: An Exploratory Study.

Paquet-Bolduc B, Gervais P, Roussy JF, Trottier S, Oughton M, Brukner I, Longtin J, Loo VG, Dascal A, Longtin Y.

Clin Infect Dis. 2018 Nov 13;67(11):1781-1783. doi: 10.1093/cid/ciy425.

PMID:
29771298
6.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH.

Clin Infect Dis. 2018 Mar 19;66(7):987-994. doi: 10.1093/cid/ciy149.

PMID:
29562266
7.

Understanding Clostridium difficile Colonization.

Crobach MJT, Vernon JJ, Loo VG, Kong LY, Péchiné S, Wilcox MH, Kuijper EJ.

Clin Microbiol Rev. 2018 Mar 14;31(2). pii: e00021-17. doi: 10.1128/CMR.00021-17. Print 2018 Apr. Review.

8.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH.

Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.

9.

Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults.

Semret M, Schiller I, Jardin BA, Frenette C, Loo VG, Papenburg J, McNeil SA, Dendukuri N.

J Infect Dis. 2017 Nov 15;216(8):936-944. doi: 10.1093/infdis/jix288.

10.

Impact of Isolating Clostridium difficile Carriers on the Burden of Isolation Precautions: A Time Series Analysis.

Xiao Y, Paquet-Bolduc B, Garenc C, Gervais P, Trottier S, Roussy JF, Longtin J, Loo VG, Longtin Y.

Clin Infect Dis. 2018 Apr 17;66(9):1377-1382. doi: 10.1093/cid/cix1024.

PMID:
29149279
11.

Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.

Bogaty C, Lévesque S, Garenc C, Frenette C, Bolduc D, Galarneau LA, Lalancette C, Loo V, Tremblay C, Trudeau M, Vachon J, Dionne M, Villeneuve J, Longtin J, Longtin Y; Quebec Clostridium difficile Infection Surveillance Program (QCISP).

Am J Infect Control. 2017 Sep 1;45(9):964-968. doi: 10.1016/j.ajic.2017.04.002. Epub 2017 May 23.

PMID:
28549882
12.

Household Transmission of Clostridium difficile to Family Members and Domestic Pets.

Loo VG, Brassard P, Miller MA.

Infect Control Hosp Epidemiol. 2016 Nov;37(11):1342-1348.

PMID:
27767004
13.

Effect Of Detecting and Isolating Asymptomatic Clostridium difficile Carriers-Reply.

Longtin Y, Gilca R, Loo VG.

JAMA Intern Med. 2016 Oct 1;176(10):1573. doi: 10.1001/jamainternmed.2016.5342. No abstract available.

PMID:
27695841
14.

Predictive computational phenotyping and biomarker discovery using reference-free genome comparisons.

Drouin A, Giguère S, Déraspe M, Marchand M, Tyers M, Loo VG, Bourgault AM, Laviolette F, Corbeil J.

BMC Genomics. 2016 Sep 26;17(1):754.

15.

A Cluster of Three Cases of Hantavirus Pulmonary Syndrome among Canadian Military Personnel.

Parkes LO, Nguyen TT, Longtin J, Beaudoin MC, Bestman-Smith J, Vinh DC, Boivin G, Loo VG.

Can J Infect Dis Med Microbiol. 2016;2016:2757969. doi: 10.1155/2016/2757969. Epub 2016 Apr 10.

16.

Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.

Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, Trottier S, Gervais P, Roussy JF, Lévesque S, Ben-David D, Cloutier I, Loo VG.

JAMA Intern Med. 2016 Jun 1;176(6):796-804. doi: 10.1001/jamainternmed.2016.0177.

PMID:
27111806
17.

Bacteremia caused by a mecA-positive oxacillin-susceptible Staphylococcus aureus strain with inducible resistance.

Kong LY, Jean A, Wong H, Semret M, Frenette C, Simor AE, Fenn S, Loo VG.

Diagn Microbiol Infect Dis. 2015 Dec;83(4):377-8. doi: 10.1016/j.diagmicrobio.2015.09.001. Epub 2015 Sep 4. No abstract available.

PMID:
26422086
18.

Accurate body composition measures from whole-body silhouettes.

Xie B, Avila JI, Ng BK, Fan B, Loo V, Gilsanz V, Hangartner T, Kalkwarf HJ, Lappe J, Oberfield S, Winer K, Zemel B, Shepherd JA.

Med Phys. 2015 Aug;42(8):4668-77. doi: 10.1118/1.4926557.

19.

Excretion of Host DNA in Feces Is Associated with Risk of Clostridium difficile Infection.

Vincent C, Mehrotra S, Loo VG, Dewar K, Manges AR.

J Immunol Res. 2015;2015:246203. doi: 10.1155/2015/246203. Epub 2015 May 18.

20.

Predictors of asymptomatic Clostridium difficile colonization on hospital admission.

Kong LY, Dendukuri N, Schiller I, Bourgault AM, Brassard P, Poirier L, Lamothe F, Béliveau C, Michaud S, Turgeon N, Toye B, Frost EH, Gilca R, Dascal A, Loo VG.

Am J Infect Control. 2015 Mar 1;43(3):248-53. doi: 10.1016/j.ajic.2014.11.024.

PMID:
25728150
21.

Macroscopic rotation of photon polarization induced by a single spin.

Arnold C, Demory J, Loo V, Lemaître A, Sagnes I, Glazov M, Krebs O, Voisin P, Senellart P, Lanco L.

Nat Commun. 2015 Feb 17;6:6236. doi: 10.1038/ncomms7236.

22.

Environmental interventions to control Clostridium difficile.

Loo VG.

Infect Dis Clin North Am. 2015 Mar;29(1):83-91. doi: 10.1016/j.idc.2014.11.006. Epub 2015 Jan 5. Review.

PMID:
25573675
23.

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update.

Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, Gerding DN.

Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S48-65. No abstract available.

PMID:
25376069
24.

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.

Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, Gerding DN.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):628-45. doi: 10.1086/676023. No abstract available.

PMID:
24799639
25.

Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection.

Vincent C, Stephens DA, Loo VG, Edens TJ, Behr MA, Dewar K, Manges AR.

Microbiome. 2013 Jun 28;1(1):18. doi: 10.1186/2049-2618-1-18.

26.

First Canadian outbreak of Enterobacteriaceae-expressing Klebsiella pneumoniae carbapenemase type 3.

Leung V, Loo VG, Frenette C, Domingo MC, Bourgault AM, Mulvey MR, Robson HG.

Can J Infect Dis Med Microbiol. 2012 Fall;23(3):117-20.

27.

HIV surveillance systems in the Asia Pacific region.

Loo V, Saidel T, Reddy A, Htin KC, Shwe YY, Verbruggen B.

Western Pac Surveill Response J. 2012 Sep 28;3(3):9-14. doi: 10.5365/WPSAR.2012.3.2.007. Print 2012 Jul.

28.

Optical nonlinearity for few-photon pulses on a quantum dot-pillar cavity device.

Loo V, Arnold C, Gazzano O, Lemaître A, Sagnes I, Krebs O, Voisin P, Senellart P, Lanco L.

Phys Rev Lett. 2012 Oct 19;109(16):166806. Epub 2012 Oct 19.

PMID:
23215114
29.

PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities.

Needle R, Fu J, Beyrer C, Loo V, Abdul-Quader AS, McIntyre JA, Li Z, Mbwambo JK, Muthui M, Pick B.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S145-51. doi: 10.1097/QAI.0b013e31825f315e. Review.

PMID:
22797736
30.

Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.

René P, Frenette CP, Schiller I, Dendukuri N, Brassard P, Fenn S, Loo VG.

Diagn Microbiol Infect Dis. 2012 May;73(1):94-6. doi: 10.1016/j.diagmicrobio.2012.01.005. Epub 2012 Mar 15.

PMID:
22424900
31.

Host and pathogen factors for Clostridium difficile infection and colonization.

Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A.

N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.

32.

Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile.

Forgetta V, Oughton MT, Marquis P, Brukner I, Blanchette R, Haub K, Magrini V, Mardis ER, Gerding DN, Loo VG, Miller MA, Mulvey MR, Rupnik M, Dascal A, Dewar K.

J Clin Microbiol. 2011 Jun;49(6):2230-8. doi: 10.1128/JCM.00391-11. Epub 2011 Apr 20.

33.

Agreement analysis of LENSTAR with other techniques of biometry.

Jasvinder S, Khang TF, Sarinder KK, Loo VP, Subrayan V.

Eye (Lond). 2011 Jun;25(6):717-24. doi: 10.1038/eye.2011.28. Epub 2011 Mar 11.

34.

Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.

McCracken M, Mataseje LF, Loo V, Walkty A, Adam HJ, Hoban DJ, Zhanel GG, Mulvey MR; Canadian Antimicrobial Resistance Alliance (CARA).

Diagn Microbiol Infect Dis. 2011 Mar;69(3):335-41. doi: 10.1016/j.diagmicrobio.2010.10.030.

PMID:
21353962
35.

Infection acquisition following intensive care unit room privatization.

Teltsch DY, Hanley J, Loo V, Goldberg P, Gursahaney A, Buckeridge DL.

Arch Intern Med. 2011 Jan 10;171(1):32-8. doi: 10.1001/archinternmed.2010.469.

PMID:
21220658
36.

Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease.

Manges AR, Labbe A, Loo VG, Atherton JK, Behr MA, Masson L, Tellis PA, Brousseau R.

J Infect Dis. 2010 Dec 15;202(12):1877-84. doi: 10.1086/657319. Epub 2010 Nov 4.

PMID:
21050115
37.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America.

Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. doi: 10.1086/651706.

PMID:
20307191
38.

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.

Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, Alfa M, Pienaar C, Kibsey P, Pitout JD.

Antimicrob Agents Chemother. 2010 Mar;54(3):1327-30. doi: 10.1128/AAC.01338-09. Epub 2010 Jan 4.

39.

The use of preserved bovine pericardium for emergency temporizing graft in corneal perforation.

Koay AC, Yew YH, Ngo CT, Loo VP, Intan G, Chua CN.

Med J Malaysia. 2008 Dec;63(5):421-2.

40.

Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile.

Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD.

Infect Control Hosp Epidemiol. 2009 Oct;30(10):939-44. doi: 10.1086/605322.

PMID:
19715426
41.

A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region.

Sharma M, Oppenheimer E, Saidel T, Loo V, Garg R.

AIDS. 2009 Jul 17;23(11):1405-13. Review.

PMID:
19579290
42.

Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.

McCracken M, DeCorby M, Fuller J, Loo V, Hoban DJ, Zhanel GG, Mulvey MR.

J Antimicrob Chemother. 2009 Sep;64(3):552-5. doi: 10.1093/jac/dkp225. Epub 2009 Jul 3.

PMID:
19578083
43.

Baseline integrated behavioural and biological assessment among most at-risk populations in six high-prevalence states of India: design and implementation challenges.

Saidel T, Adhikary R, Mainkar M, Dale J, Loo V, Rahman M, Ramesh BM, Paranjape RS.

AIDS. 2008 Dec;22 Suppl 5:S17-34. doi: 10.1097/01.aids.0000343761.77702.04.

PMID:
19098477
44.

Evaluation design for large-scale HIV prevention programmes: the case of Avahan, the India AIDS initiative.

Chandrasekaran P, Dallabetta G, Loo V, Mills S, Saidel T, Adhikary R, Alary M, Lowndes CM, Boily MC, Moore J; Avahan Evaluation Partners.

AIDS. 2008 Dec;22 Suppl 5:S1-15. doi: 10.1097/01.aids.0000343760.70078.89. Review.

PMID:
19098469
45.

Antimicrobial-associated risk factors for Clostridium difficile infection.

Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA.

Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S19-31. doi: 10.1086/521859. Review.

PMID:
18177218
46.

A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.

Hubert B, Loo VG, Bourgault AM, Poirier L, Dascal A, Fortin E, Dionne M, Lorange M.

Clin Infect Dis. 2007 Jan 15;44(2):238-44. Epub 2006 Dec 6.

PMID:
17173224
47.

Pursuing scale and quality in STI interventions with sex workers: initial results from Avahan India AIDS Initiative.

Steen R, Mogasale V, Wi T, Singh AK, Das A, Daly C, George B, Neilsen G, Loo V, Dallabetta G.

Sex Transm Infect. 2006 Oct;82(5):381-5.

48.

In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.

Bourgault AM, Lamothe F, Loo VG, Poirier L; CDAD-CSI Study Group.

Antimicrob Agents Chemother. 2006 Oct;50(10):3473-5.

49.

Containing HIV/AIDS in India: the unfinished agenda.

Chandrasekaran P, Dallabetta G, Loo V, Rao S, Gayle H, Alexander A.

Lancet Infect Dis. 2006 Aug;6(8):508-21. Review.

PMID:
16870529
50.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A.

N Engl J Med. 2005 Dec 8;353(23):2442-9. Epub 2005 Dec 1. Erratum in: N Engl J Med. 2006 May 18;354(20):2200.

Supplemental Content

Support Center